Hikma Pharmaceuticals PLC (HKMPF)
OTCMKTS · Delayed Price · Currency is USD
23.98
-1.23 (-4.90%)
At close: Oct 15, 2025
Hikma Pharmaceuticals Market Cap
Hikma Pharmaceuticals has a market cap or net worth of $5.31 billion as of October 20, 2025. Its market cap has decreased by -2.55% in one year.
Market Cap
5.31B
Enterprise Value
6.62B
Revenue
3.22B
Ranking
n/a
PE Ratio
14.32
Stock Price
$23.98
Market Cap Chart
Since November 2, 2005, Hikma Pharmaceuticals's market cap has increased from 833.84M to 5.31B, an increase of 537.14%. That is a compound annual growth rate of 9.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 5.26B | -4.84% |
| Dec 31, 2024 | 5.53B | 9.82% |
| Dec 29, 2023 | 5.04B | 22.33% |
| Dec 30, 2022 | 4.12B | -40.78% |
| Dec 31, 2021 | 6.95B | -12.23% |
| Dec 31, 2020 | 7.92B | 24.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 671.98M |
| Elite Pharmaceuticals | 660.18M |
| Veradigm | 517.28M |
| Northwest Biotherapeutics | 347.69M |
| CytoDyn | 336.10M |
| Nika Pharmaceuticals | 333.67M |
| Silence Therapeutics | 307.02M |
| American Oncology Network | 277.57M |